UMB Bank N A MO boosted its stake in shares of Cardinal Health Inc (NYSE:CAH) by 19.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,009 shares of the company’s stock after purchasing an additional 818 shares during the period. UMB Bank N A MO’s holdings in Cardinal Health were worth $236,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. Dimensional Fund Advisors LP grew its stake in shares of Cardinal Health by 41.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,447,058 shares of the company’s stock valued at $109,144,000 after buying an additional 720,871 shares during the period. Geode Capital Management LLC lifted its position in shares of Cardinal Health by 5.4% during the 4th quarter. Geode Capital Management LLC now owns 4,155,931 shares of the company’s stock worth $185,121,000 after buying an additional 213,970 shares in the last quarter. Mercer Global Advisors Inc. ADV bought a new position in shares of Cardinal Health during the 1st quarter worth approximately $950,000. WP Advisors LLC bought a new position in shares of Cardinal Health during the 1st quarter worth approximately $26,000. Finally, Toth Financial Advisory Corp lifted its position in shares of Cardinal Health by 162.9% during the 1st quarter. Toth Financial Advisory Corp now owns 18,029 shares of the company’s stock worth $868,000 after buying an additional 11,172 shares in the last quarter. Institutional investors own 89.58% of the company’s stock.
A number of equities research analysts recently commented on CAH shares. Guggenheim started coverage on shares of Cardinal Health in a report on Wednesday, April 17th. They issued a “neutral” rating and a $51.00 price target on the stock. ValuEngine raised shares of Cardinal Health from a “strong sell” rating to a “sell” rating in a report on Thursday, May 9th. Three research analysts have rated the stock with a sell rating and six have given a hold rating to the company. Cardinal Health presently has a consensus rating of “Hold” and an average price target of $54.86.
Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, August 8th. The company reported $1.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.93 by $0.18. Cardinal Health had a net margin of 0.94% and a return on equity of 25.96%. The business had revenue of $37.35 billion during the quarter, compared to analyst estimates of $36.70 billion. During the same period in the previous year, the business earned $1.01 EPS. Cardinal Health’s revenue was up 5.7% compared to the same quarter last year. On average, equities analysts expect that Cardinal Health Inc will post 5.02 EPS for the current fiscal year.
About Cardinal Health
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.
Recommended Story: What impact do institutional investors have on markets?
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc (NYSE:CAH).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.